Pittsburgh Vaccine Trials Unit

A blue-tipped syringe with a drop of liquid at the end
Pittsburgh is one of more than 100 trial sites for a vaccine being developed by AstraZeneca and Oxford. The vaccine was shown to be highly effective at combating COVID-19 in a preliminary analysis.